These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22370640)

  • 1. MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4.
    Agarwal N; Adhikari AS; Iyer SV; Hekmatdoost K; Welch DR; Iwakuma T
    Oncogene; 2013 Jan; 32(4):462-70. PubMed ID: 22370640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MDM2 binding protein, a novel metastasis suppressor.
    Iwakuma T; Agarwal N
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):633-40. PubMed ID: 22684342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTBP inhibits migration and metastasis of hepatocellular carcinoma.
    Bi Q; Ranjan A; Fan R; Agarwal N; Welch DR; Weinman SA; Ding J; Iwakuma T
    Clin Exp Metastasis; 2015 Apr; 32(4):301-11. PubMed ID: 25759210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mtbp haploinsufficiency in mice increases tumor metastasis.
    Iwakuma T; Tochigi Y; Van Pelt CS; Caldwell LC; Terzian T; Parant JM; Chau GP; Koch JG; Eischen CM; Lozano G
    Oncogene; 2008 Mar; 27(13):1813-20. PubMed ID: 17906694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Non-Coding RNA CRYBG3 Promotes Lung Cancer Metastasis via Activating the eEF1A1/MDM2/MTBP Axis.
    Wu A; Tang J; Guo Z; Dai Y; Nie J; Hu W; Liu N; Ye C; Li S; Pei H; Zhou G
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTBP regulates cell survival and therapeutic sensitivity in TP53 wildtype glioblastomas.
    Song Y; Zhang L; Jiang Y; Hu T; Zhang D; Qiao Q; Wang R; Wang M; Han S
    Theranostics; 2019; 9(20):6019-6030. PubMed ID: 31534534
    [No Abstract]   [Full Text] [Related]  

  • 7. Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck.
    Vlatković N; El-Fert A; Devling T; Ray-Sinha A; Gore DM; Rubbi CP; Dodson A; Jones AS; Helliwell TR; Jones TM; Boyd MT
    Cancer; 2011 Jul; 117(13):2939-50. PubMed ID: 21692053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis.
    Odvody J; Vincent T; Arrate MP; Grieb B; Wang S; Garriga J; Lozano G; Iwakuma T; Haines DS; Eischen CM
    Oncogene; 2010 Jun; 29(22):3287-96. PubMed ID: 20305689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of alpha-actinin 4 upon epidermal growth factor exposure regulates its interaction with actin.
    Shao H; Wu C; Wells A
    J Biol Chem; 2010 Jan; 285(4):2591-600. PubMed ID: 19920151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of p53 and MDM2 activity by MTBP.
    Brady M; Vlatkovic N; Boyd MT
    Mol Cell Biol; 2005 Jan; 25(2):545-53. PubMed ID: 15632057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin.
    Lu S; Zhou W; Wei H; He L; Li L
    Dig Dis Sci; 2015 Dec; 60(12):3681-90. PubMed ID: 26280083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACTN4 Promotes the Proliferation, Migration, Metastasis of Osteosarcoma and Enhances its Invasive Ability through the NF-κB Pathway.
    Huang Q; Li X; Huang Z; Yu F; Wang X; Wang S; He Z; Lin J
    Pathol Oncol Res; 2020 Apr; 26(2):893-904. PubMed ID: 30879239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Actinin 4 potentiates nuclear factor κ-light-chain-enhancer of activated B-cell (NF-κB) activity in podocytes independent of its cytoplasmic actin binding function.
    Zhao X; Hsu KS; Lim JH; Bruggeman LA; Kao HY
    J Biol Chem; 2015 Jan; 290(1):338-49. PubMed ID: 25411248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non‑coding RNA PCAT6 promotes the development of osteosarcoma by increasing MDM2 expression.
    Guan X; Xu Y; Zheng J
    Oncol Rep; 2020 Dec; 44(6):2465-2474. PubMed ID: 33125146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of p53 nuclear export through sequential changes in conformation and ubiquitination.
    Nie L; Sasaki M; Maki CG
    J Biol Chem; 2007 May; 282(19):14616-25. PubMed ID: 17371868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Novel splicing isoform of actin-binding protein alpha-actinin 4 in epidermoid carcinoma cells A431].
    Aksenova VIu; Khotin MG; Turoverova LV; Iudintseva NM; Magnusson KÉ; Pinaev GP; Tentler DG
    Tsitologiia; 2012; 54(1):25-32. PubMed ID: 22567897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDM2 binding induces a conformational change in p53 that is opposed by heat-shock protein 90 and precedes p53 proteasomal degradation.
    Sasaki M; Nie L; Maki CG
    J Biol Chem; 2007 May; 282(19):14626-34. PubMed ID: 17363365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Actinin-4 enhances colorectal cancer cell invasion by suppressing focal adhesion maturation.
    Fukumoto M; Kurisu S; Yamada T; Takenawa T
    PLoS One; 2015; 10(4):e0120616. PubMed ID: 25860875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation.
    Ning Y; Hui N; Qing B; Zhuo Y; Sun W; Du Y; Liu S; Liu K; Zhou J
    Cell Death Dis; 2019 May; 10(6):414. PubMed ID: 31138778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyro3-mediated phosphorylation of ACTN4 at tyrosines is FAK-dependent and decreases susceptibility to cleavage by m-Calpain.
    Shao H; Wang A; Lauffenburger D; Wells A
    Int J Biochem Cell Biol; 2018 Feb; 95():73-84. PubMed ID: 29274473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.